当前位置：首页 SCI期刊 SCIE期刊医学中科院4区 JCRQ2 期刊介绍(非官网)

Transplant Infectious DiseaseSCIE

国际简称：TRANSPL INFECT DIS 参考译名：移植传染病

中科院分区
4区
CiteScore分区
Q2
JCR分区
Q2

基本信息：: ISSN：1398-2273; E-ISSN：1399-3062; 是否OA：未开放; 是否预警：否; TOP期刊：否

出版信息：: 出版地区：UNITED STATES; 出版商：Wiley-Blackwell Publishing Ltd; 出版语言：English; 出版周期：Quarterly; 出版年份：1999; 研究方向：传染病学-医学

评价信息：: 影响因子：2.6; H-index：60; CiteScore指数：5.3; SJR指数：0.62; SNIP指数：0.628

发文数据：: Gold OA文章占比：18.67%; 研究类文章占比：73.33%; 年发文量：150

投稿咨询加急见刊

英文简介期刊介绍 CiteScore数据中科院SCI分区 JCR分区发文数据常见问题

英文简介Transplant Infectious Disease期刊介绍

Transplant Infectious Disease has been established as a forum for presenting the most current information on the prevention and treatment of infection complicating organ and bone marrow transplantation. The point of view of the journal is that infection and allograft rejection (or graft-versus-host disease) are closely intertwined, and that advances in one area will have immediate consequences on the other. The interaction of the transplant recipient with potential microbial invaders, the impact of immunosuppressive strategies on this interaction, and the effects of cytokines, growth factors, and chemokines liberated during the course of infections, rejection, or graft-versus-host disease are central to the interests and mission of this journal.

Transplant Infectious Disease is aimed at disseminating the latest information relevant to the infectious disease complications of transplantation to clinicians and scientists involved in bone marrow, kidney, liver, heart, lung, intestinal, and pancreatic transplantation. The infectious disease consequences and concerns regarding innovative transplant strategies, from novel immunosuppressive agents to xenotransplantation, are very much a concern of this journal. In addition, this journal feels a particular responsibility to inform primary care practitioners in the community, who increasingly are sharing the responsibility for the care of these patients, of the special considerations regarding the prevention and treatment of infection in transplant recipients. As exemplified by the international editorial board, articles are sought throughout the world that address both general issues and those of a more restricted geographic import.

期刊简介Transplant Infectious Disease期刊介绍

《Transplant Infectious Disease》自1999出版以来，是一本医学优秀杂志。致力于发表原创科学研究结果，并为医学各个领域的原创研究提供一个展示平台，以促进医学领域的的进步。该刊鼓励先进的、清晰的阐述，从广泛的视角提供当前感兴趣的研究主题的新见解，或审查多年来某个重要领域的所有重要发展。该期刊特色在于及时报道医学领域的最新进展和新发现新突破等。该刊近一年未被列入预警期刊名单，目前已被权威数据库SCIE收录，得到了广泛的认可。

该期刊投稿重要关注点：

预计审稿时间：偏慢,4-8周
医学
IMMUNOLOGY
SCIE
中科院4区
非预警

Cite Score数据（2024年最新版）Transplant Infectious Disease Cite Score数据

CiteScore：5.3
SJR：0.62
SNIP：0.628

学科类别	分区	排名	百分位
大类：Medicine 小类：Transplantation	Q2	16 / 54	71%
大类：Medicine 小类：Infectious Diseases	Q2	135 / 344	60%

CiteScore 是由Elsevier(爱思唯尔)推出的另一种评价期刊影响力的文献计量指标。反映出一家期刊近期发表论文的年篇均引用次数。CiteScore以Scopus数据库中收集的引文为基础，针对的是前四年发表的论文的引文。CiteScore的意义在于，它可以为学术界提供一种新的、更全面、更客观地评价期刊影响力的方法，而不仅仅是通过影响因子(IF)这一单一指标来评价。

历年Cite Score趋势图

中科院SCI分区Transplant Infectious Disease 中科院分区

中科院 2023年12月升级版 综述期刊：否 Top期刊：否

大类学科	分区	小类学科	分区
医学	4区	IMMUNOLOGY 免疫学 INFECTIOUS DISEASES 传染病学 TRANSPLANTATION 移植	4区 4区 4区

中科院分区表 是以客观数据为基础，运用科学计量学方法对国际、国内学术期刊依据影响力进行等级划分的期刊评价标准。它为我国科研、教育机构的管理人员、科研工作者提供了一份评价国际学术期刊影响力的参考数据，得到了全国各地高校、科研机构的广泛认可。

中科院分区表 将所有期刊按照一定指标划分为1区、2区、3区、4区四个层次，类似于“优、良、及格”等。最开始，这个分区只是为了方便图书管理及图书情报领域的研究和期刊评估。之后中科院分区逐步发展成为了一种评价学术期刊质量的重要工具。

历年中科院分区趋势图

JCR分区Transplant Infectious Disease JCR分区

2023-2024 年最新版

按JIF指标学科分区	收录子集	分区	排名	百分位
学科：IMMUNOLOGY	SCIE	Q3	127 / 181	30.1%
学科：INFECTIOUS DISEASES	SCIE	Q3	69 / 132	48.1%
学科：TRANSPLANTATION	SCIE	Q2	13 / 31	59.7%

按JCI指标学科分区	收录子集	分区	排名	百分位
学科：IMMUNOLOGY	SCIE	Q3	101 / 181	44.48%
学科：INFECTIOUS DISEASES	SCIE	Q2	64 / 132	51.89%
学科：TRANSPLANTATION	SCIE	Q3	17 / 31	46.77%

JCR分区的优势在于它可以帮助读者对学术文献质量进行评估。不同学科的文章引用量可能存在较大的差异，此时单独依靠影响因子(IF)评价期刊的质量可能是存在一定问题的。因此，JCR将期刊按照学科门类和影响因子分为不同的分区，这样读者可以根据自己的研究领域和需求选择合适的期刊。

历年影响因子趋势图

本刊中国学者近年发表论文

1、Infection evaluation in the early period after liver transplantation: A single-center exploration
Author: Tu, Zhen-Hua; Jin, Ping-Bo; Chen, Di-Yu; Chen, Zhi-Yun; Li, Zhi-Wei; Zhang, Bao-Shan; Zhang, Lin; Zhang, Wei; Bai, Xue-Li; Liang, Ting-Bo

Journal: TRANSPLANT INFECTIOUS DISEASE. 2023; Vol. 25, Issue 2, pp. -. DOI: 10.1111/tid.14002
2、Adenovirus infection diagnosed by metagenomic next-generation sequencing after haploidentical hematopoietic stem cell transplantation: A multicenter study in China
Author: Wu, Qiong; Wu, Yanjun; Zhao, Ye; Zhang, Yanming; Cao, Junjie; Wu, Depei; Zhou, Juying; Chen, Feng

Journal: TRANSPLANT INFECTIOUS DISEASE. 2023; Vol. 25, Issue 2, pp. -. DOI: 10.1111/tid.14054
3、Role of regulatory T cells in CD47/donor-specific transfusion-induced immune tolerance in skin-heart transplantation mice.
Author: Hu Y¹, Zhou H², Gao B², Wang G², Wang Y².

Journal: Transpl Infect Dis. 2019 Feb;21(1):e13012. doi: 10.1111/tid.13012. Epub 2018 Nov 9.
4、Treatment of chronic hepatitis C viral infection with sofosbuvir and daclatasvir in kidney transplant recipients.
Author: Huang H¹, Tang H¹, Deng H¹, Shen J¹, Zhou Q¹, Xie W¹, Wu J¹, Chen J¹.

Journal: Transpl Infect Dis. 2019 Feb;21(1):e13018. doi: 10.1111/tid.13018. Epub 2018 Nov 22.
5、Direct-acting antiviral agents for liver transplant recipients with recurrent genotype 1 hepatitis C virus infection: Systematic review and meta-analysis.
Author: Liu J^1,², Ma B², Cao W², Li M², Bramer WM³, Peppelenbosch MP², Pan Q^1,².

Journal: Transpl Infect Dis. 2019 Apr;21(2):e13047. doi: 10.1111/tid.13047. Epub 2019 Jan 21.
6、Combination antifungal treatment for invasive fungal disease after hematopoietic stem cell transplantation in children with hematological disorders.
Author: Qiu KY^1,², Liao XY^1,², Fang JP^1,², Xu HG^1,², Li Y^1,², Huang K^1,², Zhou DH^1,².

Journal: Transpl Infect Dis. 2019 Mar 12:e13066. doi: 10.1111/tid.13066. [Epub ahead of print]
7、A first report of leptospirosis after liver transplantation
Author: alicetwsong

Journal: Transplant Infectious Disease, 2016.
8、Late
Author: huangxiaojun

Journal: Transplant Infectious Disease, 2016.